Showing results (2601-2610 of 2,777) with videos related to
Sort By:
Pageof 278
Cell Stem Cell|March 30, 2021
3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degenerationKannan V Manian, Chad A Galloway, Sonal Dalvi, et al.Infectious Diseases Diagnosis & Treatment|August 6, 2021
Diagnostic Performances of Three Rapid Diagnostic Tests for Detecting HIV Infections in MaliBourahima Kone, Yeya S Sarro, Bocar Baya, et al.BMC Neurology|November 22, 2019
The protocol-guided rapid evaluation of veterans experiencing new transient neurological symptoms (PREVENT) quality improvement program: rationale and methodsD M Bravata, L J Myers, B Homoya, et al.Personality and Mental Health|November 7, 2015
Dependent personality, separation anxiety disorder and other anxiety disorders in OCDM M Mroczkowski, F S Goes, M A Riddle, et al.AIDS Research and Human Retroviruses|October 13, 2020
Short Communication: Genetic Variation in Human IL10 Proximal Promoter and Susceptibility to HIV-1 Infection in Mali, West AfricaDjeneba Dabitao, Mamadou Dembele, Michael Urbanowski, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 22, 2019
Correction: Behavioral and synaptic alterations relevant to obsessivecompulsive disorder in mice with increased EAAT3 expressionClaudia Delgado-Acevedo, Sebastián F Estay, Anna K Radke, et al.Journal of Medicinal Chemistry|December 14, 2004
2,3-diaminopyridine bradykinin B1 receptor antagonistsScott D Kuduk, Christina Ng, Dong-Mei Feng, et al.BMC Research Notes|November 8, 2017
Extensively drug resistant tuberculosis in Mali: a case reportBassirou Diarra, Yacouba Toloba, Bakary Konate, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 10, 2019
Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expressionClaudia Delgado-Acevedo, Sebastián F Estay, Anna K Radke, et al.Journal of Scleroderma and Related Disorders|July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomesAlain Lescoat, Susan L Murphy, David Roofeh, et al.Pageof 278